{
  "primary": "SMAD3",
  "interaction_type": "indirect",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "ATXN3 deubiquitinates and stabilizes SMAD3, a key mediator of TGF-β signaling, thereby enhancing the cellular response to TGF-β.",
  "functions": [
    {
      "function": "Transcriptional TGF-β Signaling",
      "arrow": "regulates",
      "cellular_process": "ATXN3 is a transcriptional regulator that influences the expression of genes within key signaling pathways, including the Transforming Growth Factor beta (TGF-β) pathway, of which SMAD3 is a critical downstream effector.",
      "effect_description": "Loss of ATXN3 in mouse embryonic fibroblasts perturbs the gene expression of several components of the TGF-β/BMP4 signaling pathway. This suggests that ATXN3's role is not to stabilize the SMAD3 protein directly, but to modulate the transcriptional landscape that governs the TGF-β signaling response. The net effect on the pathway appears to be complex, with upregulation of some components and downregulation of others.",
      "biological_consequence": [
        "ATXN3 interacts with transcriptional regulators (e.g., HDAC3, NCoR) in the nucleus → ATXN3 influences histone acetylation and gene expression → The transcription of components in the TGF-β signaling pathway is altered → The cellular response to TGF-β is modulated at the gene expression level"
      ],
      "specific_effects": [
        "Loss of ATXN3 leads to differential expression of genes in the TGF-β/BMP4 pathway.",
        "ATXN3 interacts with transcriptional co-regulators such as HDAC3 and NCoR to control target gene expression."
      ],
      "evidence": [
        {
          "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
          "journal": "PLoS One",
          "year": 2018,
          "relevant_quote": "To assess the potential normal role of ATXN3 in regulating gene expression, we compared transcriptional profiles in WT versus Atxn3 null mouse embryonic fibroblasts. Differentially expressed genes in the absence of ATXN3 contribute to multiple signal transduction pathways, suggesting a status switch of signaling pathways including depressed Wnt and BMP4 pathways and elevated growth factor pathways such as Prolactin, TGF-β, and Ephrin pathways.",
          "pmid": "30231063"
        }
      ],
      "pathway": {
        "name": "TGF-β Signaling Pathway",
        "canonical_name": "Tgf-Β Signaling Pathway",
        "ontology_id": null,
        "ontology_source": null,
        "confidence": 0.8
      },
      "pmids": [
        "30231063"
      ],
      "interaction_effect": "regulates",
      "interaction_direction": "main_to_primary",
      "function_effect": "regulation",
      "arrow_context": {
        "direct_from": null,
        "direct_arrow": "regulates",
        "net_from": "ATXN3",
        "net_arrow": "regulates",
        "mediator_chain": [],
        "is_indirect": true
      },
      "net_arrow": "regulates",
      "direct_arrow": "regulates",
      "net_effect": "regulation",
      "direct_effect": "regulation"
    }
  ],
  "arrow": "regulates",
  "direction": "main_to_primary",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": "The input claim that ATXN3 deubiquitinates and stabilizes SMAD3 is a contextual error. Primary literature indicates that ATXN3 is involved in the transcriptional regulation of the TGF-β signaling pathway, rather than directly modulating SMAD3 protein stability. Loss of ATXN3 alters the gene expression of multiple components within this pathway.",
  "mechanism": "ATXN3 is a transcriptional regulator that influences the expression of genes within key signaling pathways, including the Transforming Growth Factor beta (TGF-β) pathway, of which SMAD3 is a critical downstream effector.",
  "effect": "Loss of ATXN3 in mouse embryonic fibroblasts perturbs the gene expression of several components of the TGF-β/BMP4 signaling pathway. This suggests that ATXN3's role is not to stabilize the SMAD3 protein directly, but to modulate the transcriptional landscape that governs the TGF-β signaling response. The net effect on the pathway appears to be complex, with upregulation of some components and downregulation of others.",
  "summary": "ATXN3 interacts with SMAD3 to modulate transcriptional regulation of tgf-β signaling, ultimately affecting the cellular response to tgf-β is modulated at the gene expression level.",
  "evidence": [
    {
      "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
      "journal": "PLoS One",
      "year": 2018,
      "relevant_quote": "To assess the potential normal role of ATXN3 in regulating gene expression, we compared transcriptional profiles in WT versus Atxn3 null mouse embryonic fibroblasts. Differentially expressed genes in the absence of ATXN3 contribute to multiple signal transduction pathways, suggesting a status switch of signaling pathways including depressed Wnt and BMP4 pathways and elevated growth factor pathways such as Prolactin, TGF-β, and Ephrin pathways."
    }
  ],
  "pathways": [
    {
      "name": "TGF-β Signaling Pathway",
      "canonical_name": "Tgf-Β Signaling Pathway",
      "ontology_id": null,
      "ontology_source": null,
      "confidence": 0.8
    }
  ],
  "interaction_effect": "regulation",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 3
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 --regulates--> SMAD3:",
  "protein_a": "ATXN3",
  "protein_b": "SMAD3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-08T02:27:47.380766Z",
  "last_updated": "2025-12-08T02:27:47.380766Z"
}